35 articles, transcripts, and reports
Biotechnology company Vertex Pharmaceuticals (NASDAQ: VRTX) has reported higher earnings and revenues for the third quarter of 2021. The bottom line also exceeded Wall Street’s…
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q3 2021 Earnings Conference
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q2 2021 Earnings Conference
Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Q1 2021 earnings call dated Apr. 29, 2021 Corporate Participants: Michael Partridge — Senior Vice President of Investor Relations Reshma Kewalramani — Chief Executive…
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q1 2021 Earnings Conference
After dominating the cystic fibrosis market for quite some time, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is currently expanding its clinical programs to other diseases. While…
Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Q4 2020 earnings call dated Feb. 01, 2021 Corporate Participants: Michael Partridge — Senior Vice President of Investor Relations Reshma Kewalramani — Chief Executive…
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported fourth quarter 2020 earnings results today. Total revenues increased 15% year-over-year to $1.62 billion. GAAP net income was up…
Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: Michael Partridge — Senior Vice President, Investor Relations Reshma Kewalramani — Chief Executive Officer,…
Vertex Pharmaceuticals Inc (VRTX) Q1 2020 earnings call dated Apr. 29, 2020 Corporate Participants: Michael Partridge — Senior Vice President of Investor Relations Reshma Kewalramani — Chief Executive Officer…
